End-of-day quote
Other stock markets
|
||
- EUR | - |
|
Sales 2024 * | 10.6M 11.56M | Sales 2025 * | 6.95M 7.58M | Capitalization | 34.34M 37.45M |
---|---|---|---|---|---|
Net income 2024 * | -11M -11.99M | Net income 2025 * | -17M -18.54M | EV / Sales 2024 * | 4.84 x |
Net Debt 2024 * | 17M 18.54M | Net Debt 2025 * | 14M 15.26M | EV / Sales 2025 * | 6.96 x |
P/E ratio 2024 * |
-3.23
x | P/E ratio 2025 * |
-2.13
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.05% |
Latest transcript on MediGene AG
Managers | Title | Age | Since |
---|---|---|---|
Selwyn Ho
CEO | Chief Executive Officer | 53 | 22-07-24 |
Dolores Schendel
CTO | Chief Tech/Sci/R&D Officer | - | 14-04-30 |
Pamela Keck
IRC | Investor Relations Contact | - | 23-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 16-08-11 | |
Frank Mathias
BRD | Director/Board Member | 62 | 18-05-14 |
Anthony Man
BRD | Director/Board Member | 68 | 20-12-15 |
1st Jan change | Capi. | |
---|---|---|
+20.66% | 127B | |
+25.43% | 117B | |
+25.56% | 27.77B | |
-19.77% | 20.44B | |
-14.36% | 16.62B | |
-13.80% | 15.92B | |
-46.67% | 14.94B | |
+12.22% | 14.74B | |
+56.47% | 14.38B |